 Ironwood Pharmaceuticals, Inc. NASDAQ:IRWD Q3 2022 Results Conference Call November 3, 2022 8:30 AM ET Company Participants Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Officer Sravan Emany - Chief Financial Officer Matt Roache - Director of Investor Relations Conference Call Participants Boris Peaker - Cowen Daniel Wolle - JPMorgan Tim Chiang - Capital One Operator Hello. My name is Lisa, and I will be your conference operator today. 